THE EXPANDING scheme of the renin-angiotensin system as shown in Figure 1 , with many tentative and unproven links, is presented as the first embarkation premise. This symposium is limited to a consideration of the system leading to the generation of the end product "angiotensin."
Angiotensin availability appears to be regulated predominantly by the generating machinery and to a lesser extent by its degradation, 1 ' 2 even though overall angiotensin clearance shows adaptive increase in response to accelerated production.' 1 The concept is further strengthened if availability of angiotensin to the receptor sites is considered in terms of local generation in the organ or the tissue, rather than through a maintained level of the circulating peptide. Accordingly, the initial rate of local generation in proximity to the receptor sites may be critical. 11 Since all of the known effects of the entire system, proximate and remote, appear to be exerted through the end product generation, its control is of pivotal importance in the study of the biological importance of the renin-angiotensin system. In this regard, the possibility of a biological role for enzymes other than renin ( Fig. 1) capable, under limited conditions, of generating angiotensin I, and particularly the "tonin system," 5 capable perhaps of a direct and local genertion of angiotensin II in the tissues, also deserves a serious attention and further exploration.
For want of concrete evidence to the contrary, the measurements of plasma renin activity and concentration as employed in the recent past have been interpreted to reflect the major influence controlling angiotensin generation in various physiological as well as pathological states. Recent work on the biochemistry of the renin-substrate reaction and its components dictates a reappraisal not only of the factors regulating angiotensin generation but also of the methods used for quantification of the activity of the system.
The native form or forms of renin either during storage in the kidney or upon release into plasma remain to be fully characterized. It is now evident that renin-like activity resides in at least three molecular weight species: (1) 43,000 daltons, 6 (2) 60,000, 7 (3) 150,000. 8 Less active or inactive forms of renin of unestablished molecular weight have been identified in renal tissues or in plasma. 9 -10 Molecular mechanisms involved in the "activation" of renin following acid exposure" storage at 4°C l2i l3 or exposure to proteolytic enzymes 14 are unknown. Physiological manipulation of renin release has been shown to increase both the active and the inactive forms of renin in human plasma. 15 " 17 By means of a direct radioimmunoassay for renin substrate molecule, 18 immunologically distinct forms of renin substrate have been identified in humans under conditions of stimulated synthesis secondary to long term estrogen treatment. Evidence for the existence of multiple forms of renin substrate in the plasma of the patient with hypertension is inconclusive at present. 19 ' 20 Our previous work did not support the possibility that a different form of renin substrate was responsible for the observed higher rate of angiotensin generation in plasma from patients with hypertension than that from normal subjects. 21 Further studies on physicochemical characterization of renin substrate should answer the question of whether multiple forms of substrate with differing affinity and reaction constants with renin exist in the plasma from subjects with hypertension.
It has been demonstrated by several investigators that the in vitro rate of angiotensin generation in plasma from patients with hypertension is higher than in normal plasma, independent of the measured concentrations and activity of plasma renin and its substrate. 21 " 25 The observations are compelling evidence for the existence of naturally occurring modifiers of the renin reaction, yet none (activators and inhibitors) have been definitively identified or related to physiopathological mechanisms. 26 Observations referred to above on the accelerated rate of in vitro angiotensin generation in plasma from patients with hypertension compared with that from normal subjects and in renal venous plasma from ischemic kidneys compared with that from contralateral "normal" kidneys were made with added human renin. It may be assumed, albeit not established, that the acidification steps involved in preparation of renal renin result in the so-called "fully active renin molecule" of approximately 43,000 M.W. 27 Since equal amounts of renin were added to plasma samples under comparison with equivalent content of total renin substrate, it was concluded that the presence or absence of a factor other than renin and renin substrate was responsible for the observed differences in the rate of renin reaction. Such a modifier of renin reaction was considered to act by altering the association and/or dissociation constant of the enzyme substrate complex. Our studies 21 with an isolated homologous system of purified human renin and its substrate indicated that the addition of plasma from patients with hypertension to the isolated system caused an increase in both the K m and the V m of the system, thus supporting the evidence for the existence of an uncompetitive activator. The addition of normal plasma caused no change.
The recent findings on active vs. inactive renin and on multiple forms of renin substrate pose the question of whether alternate and/or additional mechanisms are involved in the observed "activation" of renin in plasma from subjects with hypertension. Accordingly, the observed difference in the rate of angiotensin generation in plasma from normal subjects vs. those with hypertension could theoretically be linked to (1) variations in the proportions of active vs. less active or inactive renin, (2) presence or absence of modifiers, activators, and inhibitors of renin reaction, and (3) multiple forms of renin substrate with differing reaction constants.
This brings us to the second premise. Developing methodology is available to explore and distinguish between the contributions of all of the above considered factors in influencing renin-substrate reaction. International standardization of this methodology at this stage should go far toward yielding meaningful results in various laboratories that can be compared with each other.
The kinetic constants of the renin reaction both in whole human plasma as well as with homologous purified reactants should be measured if these measurements are to be standardized internationally. The K m values in our laboratory on whole normal human plasma agree rather well with that obtained with purified human substrate. 1828 This fact provides validation for the use of isolated and purified reactants as a test system for the detection of the modifiers of renin reaction. The K m value, representing the concentration of the substrate capable of producing half-maximal rate of the enzymatic reaction, is an indicator for estimating the contribution of the prevailing substrate concentration on the rate of the end product generation. A lack of change in K m alone, however, is not sufficient evidence for or against the existence of the modifiers of renin reaction, since K m values do not necessarily reflect the dissociation constant (k 2 ) for end product generation. 29 Two other determinations in addition to the K m value can help make this assessment. First is the V m , the velocity at substrate saturation. This determination is, however, directly dependent upon the enzyme concentration. Second is the rate constant (k 2 ) which is independent of renin concentration as well as renin substrate concentration; however, renin concentration has to be defined in units that can be universally standardized. Indeed, at unit molar enzyme concentration (if known), V m becomes identical with k 2 or the "turnover number" of the enzyme. The rate constant k 2 can be calculated' 10 from the K m value and the plasma renin activity-plasma renin concentration (PRA/PRC) slope (Fig. 2) . Calculated values on 22 untreated patients with essential hypertension are given in Table 1 .
The measurement of plasma renin concentration and activity as described by Haas et al. 31 and depicted in the upper part of Figure 2 can serve as a focal point for standardized kinetic measurements only if conditions for the renin reaction are rigidly defined and standardized. The attempts at the universal application of Goldblatt units and at the use of a renin preparation as an international standard have not provided the answer. 27 A unit of renin should be defined in terms of standardized angiotensin 1 generated under rigidly standardized conditions of enzyme-substrate reaction. National Bureau of Standards is now working to prepare a standard for angiotensin I. 32 It is now well recognized that renin substrate concentration is limiting the rate of renin reaction in human plasma. 18 state or the only form as it exists in plasma. The use of heterologous substrate magnifies the latter objections. The use of plasma from nephrectomized or from estrogentreated subjects as a source of renin substrate does not ensure that the plasma being added contains or lacks modifiers of renin reaction, nor indeed that the character of the renin substrate molecule has not changed. Under standardized conditions, changes in PRA/PRC slope as indicated in Figure 2 can distinguish between the role of active vs. inactive renin (if the determination is repeated after acid dialysis) and the role of modifiers of renin reaction (slope changes with no change in PRC) in the generation rate of angiotensin.
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These considerations prompted this symposium. The published communications represent only partial proceedings. Several excellent reviews on pertinent topics were not included in view of the rising publication costs and the rapidly changing nature of the field. It is my pleasant task to thank Drs. J.A. Luetscher, F.M. Bumpus, J.O. Davis, W.F. Ganong, and J.H. Laragh, who chaired the various sessions of the conference and led the discussions. I wish to express my sincere appreciation to the members of the organizing committee, Drs. P. Eggena, J. Barrett, M. Golub, C. Thananopavarn, and Ms. Betty Cooner, who worked diligently to make the symposium arrangements. My sincere gratitude also goes to the members of the publication committee and all of the participants who contributed to the success of the symposium. IN VIEW OF the importance of renin, a number of attempts to isolate human renin have been made. 1 " 6 The instability of purified renin and its low concentration in the kidney presented great difficulties. New techniques for renin purification, such as affinity chromatography and chemical elimination of contaminating proteases in kidney extracts, have permitted isolation of pure and stable renin from hog kidney. 7 Since the bacterial pentapeptide pepstatin 8 had been shown to inhibit human renin, 9 we have designed an affinity chromatographic technique using pepstatin-aminohexyl-agarose gel for its purification.
Methods
STARTING MATERIAL
As the starting material for this purification work, the step 7 preparation of Haas et al. 2 was used. It had a specific activity of 0.24 Goldblatt unit/mg protein (GU/ mg)-AFFINITY GEL
The preparation of pepstatin-aminohexyl-agarose is a modification of the method described for hog renin." Aminohexyl-agarose gel was prepared from agarose (Sepharose 4B; Pharmacia) and diaminohexane (Eastman) by CNBr activation essentially by the method of March et al. 10 Agarose beads (10 ml wet gel) were suspended in 20 ml of 2 M Na 2 CO 3 to which were added under vigorous stirring 2 g of CNBr dissolved in 0.25 ml of acetonitrile. The reaction was allowed to continue for 3 minutes at room temperature, and ice flakes were added to the reac- The reaction was allowed to proceed for 16 hours at 4°C. After exhaustive washing with 0.5 M NaCI (500 ml), methanol (500 ml), water (500 ml), dioxane (500 ml), and purified, anhydrous, peroxide-free dioxane" (200 ml), the gel was suspended in 16 ml of the purified dioxane. To this was added the A/-hydroxysuccinimide ester of pepstatin which had been prepared by allowing 25 mg of pepstatin to react with 10 mg of /V-hydroxysuccinimide and 1 5 mg of dicyclohexyl carbodiimide in 8 ml of purified dimethyl formamide. The coupling of the pepstatin ester to the aminohexyl agarose was allowed to proceed for 22 hours at room temperature with gentle stirring. Pepstatin-aminohexyl-agarose gel thus obtained was collected over a coarse sintered glass filter, washed successively with 500 ml of dimethyl formamide-dioxane mixture (1:2, v/v), 500 ml of 1 M NaCI, 300 ml of 4 M urea, and 11 ml of water. The amount of pepstatin covalently incorporated in 1 ml of wet gel ranged between 2.2 and 2.8 /xmoles. This was determined by amino acid analysis of the acid hydrolysate obtained by heating the wet gel in a sealed tube with an equal volume of concentrated HC1 for 24 hours at 110°C.
Renin activity was determined by the rate of angiotensin I production in 0.1 M Tris buffer, pH 7.5, at 37° for 1 hour from partially purified hog substrate (Miles Laboratories). The generated angiotensin I was determined by the radioimmunoassay method of Haber et al. 12 using an assay kit obtained from New England Nuclear.
Protein concentration was determined by the method of Waddel. 13 In column chromatographic purification, protein concentration was determined by following the
